Johnson & Johnson advised Coronavirus simulation and now stands to gain financially with new vaccine
Prior to the coronavirus outbreak, The Johns Hopkins Center for Health Security hosted Event 201, a high-level pandemic exercise focused on a coronavirus outbreak — yes they ran a simulation of exactly what we see unfolding right now, before it happened!
The pandemic exercise was conducted in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation. During Event 201 Johnson & Johnson was asked specifically about a coronavirus vaccine.
When asked, the Johnson & Johnson representative talked about the need for regulatory flexibility for an accelerated vaccine, financing and business. Not once did he mention safety or effectiveness. In today’s news, we see that Johnson & Johnson are currently working on a vaccine and they’re “pretty confident” they can quickly develop one.
Did Bill Gates & World Economic Forum Predict Coronavirus Outbreak? An Inside Look May Shock You!
J&J scientific officer ‘pretty confident’ they can create coronavirus vaccine as outbreak widens
Pirbright’s livestock coronavirus research – your questions answered
Posted: 24 January, 2020
……….The Institute holds Patent no. 10130701 which covers the development of an attenuated (weakened) form of the coronavirus that could potentially be used as a vaccine to prevent respiratory diseases in birds and other animals. Many vaccines are made in this way, from flu to polio. We have not yet developed an IBV vaccine, but research is ongoing.
The Institute is strategically funded by the Biotechnology and Biological Sciences Research Council, part of UK Research and Innovation (BBSRC UKRI) and also receives funding from many other organisations including the Bill & Melinda Gates Foundation. The patented work was not funded by the Bill & Melinda Gates Foundation. More information on The Livestock Antibody Hub which is funded by the Bill & Melinda Gates Foundation is available on our website…………